Innovative Therapies | Transforming Lives

Partnering

Partnering and Collaborations

Kineta is actively seeking strategic partnerships aimed at advancing our development pipeline. Beyond partnerships with industry, we also have a strong interest in establishing collaborative research agreements.  We actively collaborate with a broad array of private, government, biodefense and industry partners to advance our innovative research.

To further explore partnering and collaboration opportunities with Kineta, please email us or call 206-378-0400.

Kineta Collaborators

Chronic Pain Collaborators

Kineta’s Chronic Pain Program is being conducted in collaboration with the following organizations:

Gregory William Terman M.D., Ph.D.

US Army Institute of Surgical Research

University of Florence

University of Utah


LHF-535 Collaborators

Kineta’s LHF-535 (Lassa fever) program is being performed with funding from the following organizations:

Wellcome Trust

NIH


Innate Immune Antiviral Collaborators

Kineta’s Innate Immune Antiviral program is being conducted in collaboration with leading infectious disease researchers at the following organizations:

NIH

University of Washington

University of Texas, Galveston


Vaccine Adjuvant Collaborators

Kineta’s Vaccine Adjuvant program is being conducted in collaboration with infectious disease researchers at the following organizations:

NIH

Mount Sinai School of Medicine

St. Jude Children’s Hospital

University of Washington

Vaccine and Gene Therapy Institute

Inimmune